DALVOCANS

This brand name is authorized in Estonia, Croatia, Lithuania, Poland, Singapore

Active ingredients

The drug DALVOCANS contains one active pharmaceutical ingredient (API):

1 Caspofungin UNII VUW370O5QE - CASPOFUNGIN ACETATE

Caspofungin acetate is a semi-synthetic lipopeptide (echinocandin) compound synthesised from a fermentation product of Glarea lozoyensis. Caspofungin acetate inhibits the synthesis of beta (1,3)-D-glucan, an essential component of the cell wall of many filamentous fungi and yeast. Beta (1,3)-D-glucan is not present in mammalian cells. Read about Caspofungin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J02AX04	Caspofungin	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AX Other antimycotics for systemic use
Discover more medicines within J02AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1693346, 1693357
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-241627075, HR-H-673508730
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1077703, 1077704
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100382292, 100382317
Country: SG	Health Sciences Authority	Identifier(s): 15551P, 15552P